20S proteasome from LMP7 knock out mice reveals altered proteolytic activities and cleavage site preferences  by Stohwasser, R. et al.
FEBS 16724 FEBS Letters 383 (1996) 109-113 
20S proteasome from LMP7 knock out mice reveals altered proteolytic 
activities and cleavage site preferences 
R. Stohwasser a, U. Kuckelkorn% R. Kraft b, S. Kostka b, P.-M. KloetzeP,*  
~Institut fiir Biochemie der CharitY, Humboldt Universitgit, Berlin, Hessische Str. 3~, D-lOll5 Berlin, Germany 
t~Max Delbrfick Centrum fffr Molekulare Medizin, Robert-R6ssle Str. 10, D-13122 Berlin-Buch, German3, 
Received 22 August 1995; revised version received 17 November 1995 
Abstract 20S proteasomes of tissues from LMP7 knock out 
mice which show reduced MHC class I restricted antigen 
presentation were analyzed with regard to their subunit 
composition, peptide hydrolyzing activity and their ability to 
cleave a synthetic 25-mer polypeptide. LMP7 deficiency results 
in an enhanced incorporation of subunit MB1 and in a 2-3.8-fold 
increase in Vmx for the Snc-LLVY-MCA hydrolyzing activity. 
Since LMP7 deficiency also affects the cleavage site preference 
of 20S proteasomes the reduced MHC class I antigen presenta- 
tion of LMP7 knock out mice is most likely due to an 
impairment in peptide generation. 
K, T words: 20S Proteasome; LMP7 knock out mouse; 
Sttbunit MB1 peptidase activity 
1. Introduction 
The 20S proteasome is the proteolytic ore of several intra- 
cellular high molecular mass multisubunit proteinase com- 
plexes. ATP-dependent assembly of the 20S proteasome and 
a regulatory 19S complex results in the formation of the 26S 
p~ oteasome, which is involved in ubiquitin-dependent protein 
degradation [1]. Association of 20S proteasome with the l lS 
regulator complex constitutes another proteinase complex 
~ taich stimulates the peptide hydrolyzing activity and the pro- 
teinolytic activity in vitro [2,3]. With regard to function the 
20S proteasome seems to occupy a central role in intracellular 
p~otein metabolism, being involved in processes uch as cell 
c) cle [4], apoptosis [5], transcriptional regulation [6], and cel- 
h~lar immune response [7]. Its role in the generation of pep- 
tides which bind to MHC class I molecules was recently de- 
monstrated by the use of inhibitors of proteasome function 
[~l. 
The 20S proteasome complex is a dynamic cellular struc- 
ttre, which conditionally can alter its subunit composition 
a~ld function. Three of the 14 constitutively expressed sub- 
ufits can be supplemented by the homologous subunits, 
I~[ECL1, LMP2 and LMP7, which are incorporated into the 
20S proteasome complex in response to interferon- 7 (IFN-~,). 
~[he incorporation of LMP2 results in the substitution of sub- 
u fit 8, MECL1 replaces subunit Z and LMP7 substitutes 
sttbunit MB1 [9-11]. 
The IFN- 7 inducible LMP2 and LMP7 subunits which are 
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MCA, 7-amido-4-methylcoumarin; MHC, major histocompatibility 
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t~ansporter associated with antigen presentation. 
encoded within the MHC class II region in close neighbour- 
hood to the peptide transporter genes TAP1 and TAP2 are 
non-essential with regard to the viability of ceils and their 
presence is not a prerequisite for antigen presentation 
[12,13]. Nevertheless, they are assumed to play an important 
role in modifying the antigen processing capacity of a cell 
[14,15]. The mechanism by which single subunits may alter 
the peptide set presented to CD8 + T lymphocytes i  still con- 
troversial, but from cytokine induced and transfectant cell 
lines there exists experimental evidence that LMP incorpora- 
tion changes proteasome subunit composition and the protea- 
somal peptide and polypeptide cleavage properties [15-17]. 
Furthermore, recent results from LMP2 and LMP7 knock 
out mice [18,19] show that LMPs can affect MHC class I 
expression at the cell surface. Thus MHC class I surface ex- 
pression of H-2K, H-2D and I-A molecules and presentation 
of an endogenous elf-antigen was significantly reduced in 
LMP7 deficient mice compared with that of wildtype litter- 
mate controls [19]. In contrast, breeding, health status and the 
numbers of T and B lymphocytes in the peripheral lymphoid 
organs of mice was not influenced by the LMP7 deficiency 
[19]. To explain this observation the authors discussed the 
possibility that the LMP7 subunit might be a docking mole- 
cule that physically links the proteasome and the TAP trans- 
porters to increase the efficiency of peptide translocation i to 
the endoplasmic reticulum or alternatively, that LMP7 alters 
the cleavage properties of the 20S proteasome complex and in 
consequence influences the generation of antigenic peptides 
[191. 
In the present communication we therefore isolated 20S 
proteasomes from LMP7 knock out mice and analysed their 
subunit composition and proteolytic activities in response to 
the LMP7 deficiency. 
2. Materials and methods 
2.1. Purification of 20S proteasomes from mouse tissue 
Proteasomes from wild-type mice and from mice lacking LMP7 
(C57BL/6 or 129/Ola; H-2 b [19]) were purified in parallel and were 
stored under identical conditions at each step of the purification pro- 
cedure. 
Tissues of 10 mice were dispersed (T25 Ultra-Turrax/$25 N-10 G; 
Janke & Kunkel, Staufen, Germany) in 10 (thymus, spleen) to 30 ml 
(liver) lysis buffer A (80 mM KAc, 5 mM MgAc2, 10 mM HEPES, 
pH 7.2) and were further processed using a Dounce homogenizer. The 
purification procedure was continued by DEAE-Sephacel chromato- 
graphy, sucrose gradient centrifugation and Mono-Q chromatography 
[3]. Protein quantification, analysis of 20S proteasome subunit com- 
position by non-equilibrium two-dimensional electrophoresis and 
measurement of peptidase activities were carried out as previously 
described [15]. 
2.2. Assay of 20S polypeptide cleavage properties 
To analyze the polypeptide cleavage properties we used a synthetic 
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Fig. 1. Analysis of 20S proteasomes from LMP7 knock out mice by immunoblot analysis. Left panel: Ponceau-stained SDS-PAGE pattern of 
sucrose gradient purified liver 20S proteasomes from LMP7-deficient ( - - )  knock out mice, from heterozygous mice (+-) or from wild-type lit- 
termate controls (++). Only the proteasome subunit region of the blot is shown. Right panel: immunoblot probed with polyclonal rabbit anti- 
LMP7 antiserum [21]. 5 ~tg of purified RMA cell derived mouse 20S proteasome were loaded as control. 
25-mer polypeptide RLMYDMYPHFMPTNLGPSEKRVWMS de- 
rived from the sequence of murine cytomegalovirus pp89 IE protein 
[20]. The 25-mer peptide covers the antigenic nonamer region (under- 
lined). 20 I.tg peptide were dissolved in 300 ~tl of buffer (20 mM 
HEPES/NaOH, pH 7.8, 2 mM MgAc2, 1 mM dithiothreitol) and 
digested with 1 txg purified proteasome for 48 h at 37°C. Kinetic 
studies revealed, that proteolysis was completed after 24 to 48 h [3] 
(data not shown). 
75 I.tl of the peptide mixtures were separated by reversed HPLC 
using a mRPC C2/C18; SC2, 1/10 column, Pharmacia LKB, and 
Pharmacia LKB equipment (SMART system). Eluents: Solution 
A = 0.1% TFA in water (v/v); Solution B = 0.1% TFA in acetonitrile; 
flow rate= 100 B1/min. Gradient used: 0-10 min, 10% B; 10-70 min, 
linear increase to 50% B; 70-90 min, 90% B, 9~95 min held at 90% 
B; 95-105 min, decrease to 10% B; 15 min equilibrated at 10% B 
before the start of a new run. 
3. Results and discussion 
3.1. Proteasomes from LMP7- -  mice reveal altered subunit 
composition 
To study the influence of LMP7 deficiency on the biochem- 
ical properties of the 20S proteasome the enzyme complex was 
isolated from tissues of mice which carry or lack the LMP7 
gene. Previously, the absence of the LMP7 gene was con- 
firmed only by Southern blot analysis [19]. Therefore to as- 
certain the erased expression of the LMP7 protein and to 
exclude the occurrence of additional non-MHC-linked 
LMP7 or LMP7-1ike genes we checked LMP7 subunit expres- 
sion by immunoblotting with an LMP7 specific antibody. Par- 
tially purified proteasome from liver of wild-type (LMP7 ++) 
mice and mice heterozygous (LMP7 -+) or homozygous 
(LMP7--) with respect o the LMP7 deletion was subjected 
to SDS-PAGE and immunoblot analysis. As shown in Fig. 1 
LMP7 can be detected in proteasomes of LMP7 ++ mice, but 
is absent in LMP7--  mice. In heterozygous LMP7 +- mice 
the LMP7 subunit is also detectable. Since we did not obtain 
any other immune-signal these data demonstrate hat there 
exists no other LMP7 gene or LMP7 homologous gene which 
encodes a protein which can be detected by the LMP7 anti- 
body. As calculated from the amount of purified RMA cell 
proteasome loaded (5 p.g) and the LMP7 signal obtained by 
immunoblotting only approximately 30% of the mouse liver 
proteasomes contain the LMP7 subunit. This is in agreement 
with previous data showing that different issues and cell lines 
can differ in their relative amount of LMP containing 20S 
proteasomes [21]. 
Presuming that altered MHC class I surface expression in 
LMP7-deficient mice might be due to alterations of subunit 
composition and in consequence proteasome function we pur- 
ified proteasomes of thymus, spleen and liver and analyzed 
proteasomal subunit composition by 2D gel electrophoresis. 
20S proteasome purified from thymus (Fig. 2A) reveals a 20S 
proteasome pattern of 16 subunits in a molecular range of 21- 
31 kDa. Additional protein spots are most likely due to mod- 
ifications of proteasomal subunits. Individual subunits were 
identified by immunoblot (LMP7, LMP2) and protein sequen- 
cing (MB1, LMP2 and LMP7). Comparison of subunit pat- 
tern of LMP7 ++ and LMP7--  proteasome reveals that the 
disappearance of the LMP7 protein is accompanied by an 
increased incorporation of the homologous ubunit MB1 
into the 20S proteasome (Fig. 2A-C). The absence of LMP7 
has no obvious influence on the amount of LMP2 or any 
other proteasome subunit as has been suggested before 
[14,22]. 
3.2. Absence of LMP7 increases the peptidase activities both in 
tissue and transfectant 20S proteasome 
To determine the influence of LMP7 deficiency on the pep- 
tidase activities of 20S proteasomes in tissues of LMP7 knock 
out mice we monitored the enzymatic activities using the 
fluorogenic peptide substrates Suc-LLVY-MCA (chymotryp- 
sin-like; CHT-L), Z-LLE-~NA (peptidyl-glutamyl-peptide-hy- 
drolyzing activity; PGPH) and Bz-VGR-MCA (trypsin-like) 
(Fig. 3). Analysis of the kinetic parameters eveals that LMP7 
deficiency results in an approximately 74% increase of the 
CHT-L activity of 20S proteasome from thymus. In contrast, 
the lack of LMP7 had almost no significant effect on the 
PGPH activity and the trypsin-like hydrolytic activity (Table 
1; Fig. 3AC).  As judged by the chymotrypsin-like activity 
the lack of LMP7 had no significant influence on S0.5 or on 
the positive cooperative between proteasome subunits as de- 
termined by the Hill coefficient (Table 1). These results are in 
good agreement with data obtained with proteasomes from 
the transfectant human T2/LMP2+/LMP7 + ('wild-type situa- 
tion') and the T2/LMP2 cell line which expresses LMP2 but 
lacks LMP7 (Table 2 [15]). In 20S proteasomes from thymus 
and spleen of LMP7 knock out mice the increase in CHTL 
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activity coincides with the enhanced incorporation of subunit 
MB1 (Fig. 2A-C). In contrast here exists no detectable in- 
crease in MB1 incorporation i to liver 20S proteasomes (Fig. 
2D). 
Different issues have been shown to differ in their amount 
of LMP mRNAs and LMP protein levels [21]. Hepatocytes 
co~ltain low amounts of LMP mRNA. Nevertheless LMP7 
can be detected by Western blot analysis of sucrose gradient 
fractions from liver extracts (Fig. 1) which is most likely due 
to higher levels of LMP7 in liver macrophages. 
Purification of 20S proteasomes was performed under con- 
di ions known to completely remove the l lS regulator and 
amino-peptidases which could influence nzyme kinetics [23]. 
Minor amounts of high molecular weight proteins present in 
some proteasome preparations were identified as 19S regula- 
to; components of the 26S protease (data not shown). How- 
e~ er, independent proteasome preparations did not affect pep- 
tidase activity profiles in response to LMP7 deletion (Table 2). 
F trthermore xperiments in which the aldehyde inhibitor N- 
bcnzyloxycarhonyl-Ile-Glu-(O-t-butyl)-Ala-leucinal (Z-IE- 
((~tBu)-AL-CHO) was used [24], demonstrated that the pro- 
teasomal chymotrypsin-like activity is inhibited in a dose-de- 
p~:ndent manner (Fig. 3F). An inhibitor concentration of 0.25 
~V[ reduces the CHTL activity down to 44% and 42%, respec- 
tively, whereas PGPH remains unaffected. 
From our data it can be deduced that the presence of both 
1_ MP2 and LMP7 in 20S proteasomes of different mouse tis- 
st~es results in a relative down regulation of Suc-LLVY-MCA 
h.~drolyzing activity since proteasomes of tissues with low 
LMP2 levels such as liver (Fig. 3E) reveal a higher Sue- 
[ LVY-MCA hydrolyzing activity than proteasomes of tissues 
ith high LMP2 content (thymus, spleen; Fig. 3A,D). This 
s~ands in contrast o experiments performed with crude ex- 
tracts of LMP2 knock out mice (i.e. LMP7 + mice) in which a 
nqative decrease of Suc-LLVY-MCA hydrolyzing activity was 
o~served [18]. Crude extracts contain a number of other pro- 
kinase complexes for which Suc-LLVY-MCA can serve as 
substrate [3,23]. Therefore enzyme activity measurements of 
i~dependently obtained tissue extracts without chromato- 
graphic purification of the proteasome complex may lead to 
¢ mtradictory results. 
In summary, our experiments show that despite the fact 
trot tissues normally represent a collection of different cell 
tvpes the enzymatic properties of 20S proteasomes from tis- 
saes of mutant mice are compatible with data obtained with 
20S proteasome of clonal cell lines {15]. 
. 3. Polypeptide cleavage properties of LMP7- - -  and 
LMP7++-20S proteasomes are different 
To address the question whether deletion of LMP7 influ- 
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Fig. 2. Two-dimensional gel electrophoresis and silver staining of 
purified 20S proteasomes (10 btg) isolated from thymus (A,B), spleen 
(C) and liver (D). (A) Demonstrates the wild-type proteasome pat- 
tern of control mice (LMP7++). (B-D) shows tissue specific pattern 
from mice lacking LMP7 (LMP7--). (E) Identification of proteaso- 
mal subunits: 14 = MB1, 15 = LMP7, 16 = LMP2. Arrows in panel 
A mark subunits MBI, LMP7 and LMP2. Arrows in panel B, C 
and D mark subunit MB1, whose amount is increased, and subunit 
LMP2. Subunit LMP7 is missing (circle). 
Table 1 
~.inetic parameters of hydrolysis of fluorogenic peptides performed by 20S proteasomes from thymus 
Suc- Leu-Leu-Val-Tyr-MCA Bz-VaI-GIy-Arg-MCA 
LMP7 ++ LMP7-- LMP7 ++ LMP7-- 
Z-Leu-Leu-Glu-I~NA 
LMP7 ++ LMP7-- 
%a~ 0.72 + 0.02 2.72 + 0.07 3.46 + 0.46 3.53 + 0.27 8.78 + 0.69 8.88 +_ 0.24 
":0.5 28.30 + 2.20 27.40 + 1.60 115.9 + 38.8 197.9 + 32.1 221.8 + 27.8 124.6 + 5.7 
t 2.04 _+ 0.35 2.49 + 0.39 1' 1' 1.40 + 0.10 1.64 _+ 0.07 
For data calculation, a kinetic Hill model was used: v = Vm~x/[1 +(SISo.s) HI [27]. Data are mean values + standard error of the mean 
IS.E.M.) from three separate determinations (n = 3). Vm~ = maximal reaction velocity in nmol/h/~tg proteasome; S0.s = Michaelis constant in 
~tM; H = Hill coefficient. 
Value was fixed to H = 1 because of the large redundancy between S0.5 and H. 
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Fig. 3. Effect of LMP7 deficiency on peptidase activities of proteasomes i olated from thymus (A, B, C and F), spleen (D), and liver (E). 
Fluorogenic peptide substrates were digested at indicated concentrations by application of 100 ng purified proteasome. Filled symbols are indi- 
cating LMP7-- knock out proteasomes, LMP7 ++ proteasomes isolated from wild-type control mice are symbolized by open symbols. (F) Inhi- 
bition of chymotrypsin-like, but not of the PGPH activity by proteasome inhibitor Z-IE-(OtBu)-AL-CHO. Fluorogenic peptide substrates were 
applied at a concentration f 400 I.tM. 
ences the ability of the proteasomes from tissue of mutant 
mice to generate specific peptides from a larger peptide sub- 
strate we used a synthetic 25-mer peptide derived from the 
sequence of Murine Cytomegalovirus pp89 IE protein [20] 
as substrate for proteasomes. The 25-mer peptide covers the 
antigenic nonameric T-cell epitope (H-2D) of pp89. Peptide 
digests were subjected to HPLC analysis. As shown in Fig. 4 
the cleavage pattern generated by 20S proteasomes from 
mouse thymus or spleen differs significantly dependent on 
the presence or absence of the LMP7 subunit. For more de- 
tailed analysis the sequence of the cleavage products collected 
from several peaks was determined by N-terminal peptide 
sequencing. The analysis of HPLC product files reveals that 
LMP7 influences the cleavage site preference of the 20S pro- 
teasome. Thus the relative amount of the DMYPHFMPTNL 
11-mer product (peak 4, aa positions 5-15) generated by dual 
cleavages and of peptide GPSEKRVWMS (Peak l, aa posi- 
tions 16-25) are reduced in LMP7- -  proteasome digests. On 
the other hand proteasomes from LMP7 knock out mice gen- 
erate more efficiently the PHFMPTNL 8-mer peptide (peak 3, 
aa positions 8-15). The increase in the Ps-L15 8-mer generated 
by dual cleavages is accompanied by an increase of peptide 
RLMYDMY (aa positions 1-7). Thus LMP7 deficiency in 
proteasomes of mouse tissues leads to a change in cleavage 
site preference. 
Recently we were able to show that using purified 20S pro- 
teasome in in vitro antigen processing experiments closely 
reflects the in vivo situation [25]. Thus based on the experi- 
ments reported here, the previously observed reduction in 
MHC class I surface expression in LMP7 knock out mice 
Table 2 
Comparison of V~n~, of hydrolysis of fluorogenic peptides in tissues and transfectant T2 cell lines 
Substrate Vm~ of peptide hydrolysis in various LMP phenotypes Ref. 
LMP2 + LMP2 + Percentage of change Origin of proteasome 
LMP7 + LMP7- 
Suc-L-L-V-Y-MCA 0.72 + 0.02 2.72 + 0.07 +74 Thymus This work 
Z-L-L-E-I3NA 8.78 + 0.69 8.88 + 0.24 +0 Thymus This work 
Bz-V-G-R-MCA 3.46 + 0.46 3.53 + 0.27 +0 Thymus This work 
Suc-L-L-V-Y-MCA 1.20 + 0.04 3.00 + 0.10 +60 Spleen This work 
Suc-L-L-V-Y-MCA 5.09 + 0.22 9.99 + 0.42 +49 Liver This work 
Suc-L-L-V-Y-MCA 9.89 + 1.37 18.9 + 1.40 +48 Liver This work 
Suc-L-L-V-Y-MCA 1.56 6.72 +77 T2 transfectant [15] 
Z-L-L-E-I$NA 0.77 0.59 -23 T2 transfectant [15] 
Calculation of the 'percentage of change' value was performed by setting Vm~, of the LMP7 mutant as 100%. Vm~ in nmol/h/Ixg proteasome; 
data are mean values + S.E. of the mean (S.E.M.) (n = 3). Data from two separate liver 20S proteasome purifications are shown. 
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1-g. 4. Analysis of the polypeptide cleavage properties of 20S proteasomes from thymus (A, B) and spleen (C, D) of control mice (upper pa- 
nt~ls: A, C) and of mice lacking LMP7 (lower panels: B, D). MCMV pp89 protein derived synthetic 25-mer peptide RLMYD- 
I~YPHFMPTNLGPSEKRVWMS was digested for 48 h with 1 pg proteasome. Cleavage products were separated by reverse phase HPLC. 
Numbers are indicating N-terminal sequenced peak fractions: 1 = GPSEKRVWMS (aa positions 16-25) 2 = RLMYDMY (aa positions 1-7); 
3 = PHFMPTNL (aa positions 8-15); 4 = DMYPHFMPTNL (aa positions 5-15). 
n ray be explained by partial impairment of peptide generation 
d ae to the imbalance of LMP subunits. It has to be pointed 
c~dt, however, that despite our increased knowledge on pro- 
tcasomal antigen processing activities, precise predictions con- 
cerning potential effects of the LMP subunits on antigen pre- 
sentation are so far not yet possible and observed positive or 
negative ffects may have been dependent on the type of anti- 
gen analysed [26]. 
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